Skip to Content

C 92 (Rivastigmine Tartrate 3 mg)

Pill with imprint C 92 is Orange, Capsule-shape and has been identified as Rivastigmine Tartrate 3 mg. It is supplied by Cadila Pharmaceuticals Limited.

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 3 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 92

Rivastigmine tartrate 3 mg C 92

Rivastigmine Tartrate

Imprint
C 92
Strength
3 mg
Color
Orange
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cadila Pharmaceuticals Limited
National Drug Code (NDC)
71209-0013
Inactive Ingredients
hypromelloses, microcrystalline cellulose, silicon dioxide, magnesium stearate, gelatin, titanium dioxide, ferric oxide yellow, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C 92"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.